(Q33700576)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428038%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

review article

1 reference

title

Alzheimer's disease and the amyloid beta protein: What is the role of amyloid? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428038%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428038%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

author name string

D H Small

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428038%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

language of work or name

English

0 references

publication date

1 August 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428038%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neurochemistry

10 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428038%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

volume

73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428038%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428038%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

page(s)

443-449

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428038%20AND%20SRC:MED&resulttype=core&format=json

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

10 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Hydrogen peroxide mediates amyloid beta protein toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

beta-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Oxidative stress after acute and chronic application of beta-amyloid fragment 25-35 in cortical cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Release of excess amyloid beta protein from a mutant amyloid beta protein precursor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Image analysis of beta-amyloid load in Alzheimer's disease and relation to dementia severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Amyloid beta-peptide (A beta P) potentiates a nimodipine-sensitive L-type barium conductance in N1E-115 neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Cleavage of amyloid beta peptide during constitutive processing of its precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Potentially Amyloidogenic, Carboxyl-Terminal Derivatives of the Amyloid Protein Precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Effects of injected Alzheimer beta-amyloid cores in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Processing of the Amyloid Protein Precursor to Potentially Amyloidogenic Derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Amyloid beta-peptide is produced by cultured cells during normal metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Amyloid, the presenilins and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Alzheimer's disease: the amyloid cascade hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Aggregation State and Neurotoxic Properties of Alzheimer Beta-Amyloid Peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Transgenic mice expressing Alzheimer amyloid precursor proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

A detergent-insoluble membrane compartment contains A beta in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

A68: a major subunit of paired helical filaments and derivatized forms of normal Tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Amyloid plaque core protein in Alzheimer disease and Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Increased Abeta42(43) from cell lines expressing presenilin 1 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Mis-sense mutation Val&rarr;Ile in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Oligomerization of endogenous and synthetic amyloid beta-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Alzheimer's disease: a description of the structural lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Apolipoprotein E affects the rate of Alzheimer disease expression: beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Clinical correlates of cortical and nucleus basalis pathology in Alzheimer dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Alzheimer's disease: genotypes, phenotypes, and treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Detection of a novel intraneuronal pool of insoluble amyloid beta protein that accumulates with time in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

The role of the amyloid protein precursor (APP) in Alzheimer's disease: does the normal function of APP explain the topography of neurodegeneration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Tau protein pathology in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

21 January 2018

Alzheimer's mutation.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Genomic organization of the human amyloid beta-protein precursor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Amyloid-β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Neuron loss in APP transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X

Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730443.X